Ozette
Founded 2021 · 30 employees on LinkedIn · 4 known investors
Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials. It serves biopharma clinical development teams, discovery/R&D groups, and academic labs, operating under a validated (GCLP-compliant) quality system.
Founders & leadership
Ozette was founded in 2021 by Greg Finak, Evan Greene, and Ali Ansary.
Investors · 4
Competitors · 2
by search overlapSoundCloud3 shared keywordsAudio distribution and music-sharing platform for artists and creators.
Incyte Corporation3 shared keywordsIncyte is a global biopharmaceutical company that develops medicines across hematology, oncology, and inflammation and autoimmunity, with clinical programs spanning areas such as dermatology. It focuses on research and development of treatments for patients.
Companies competing with Ozette for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Ozette do?
- Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials. It serves biopharma clinical development teams, discovery/R&D groups, and academic labs, operating under a validated (GCLP-compliant) quality system.
- Who founded Ozette?
- Ozette was founded by Greg Finak, Evan Greene, Ali Ansary in 2021.
- Who are Ozette's investors?
- Ozette's investors include Allen Institute for AI (AI2) Incubator, Alpha Ascent Ventures Llc, M12 (Microsoft's Venture Fund), Madrona Venture Group.